Remodulin Solution For Injection 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Remodulin: Solution for injection (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

TREPROSTINIL is used to treat pulmonary arterial hypertension. This medicine helps to improve symptoms and quality of life.

In-Depth Information

Remodulin 10mg/ml Solution for Injection

NDC: 663020110
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Pulmonary Hypertension

Sometimes used for but not FDA approved for the following conditions:
Claudication

Storage Information
Do not use more than 30 days after opening
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Remodulin 10mg/ml Solution for Injection

Reported Side Effects for Remodulin 10mg/ml Solution for Injection

Intestinal Bleeding Incidence:
1.3%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
>3.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
>3.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
3.0-6.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
>3.0%*
Severity: MILD
Onset: DELAYED
Low Blood Pressure Incidence:
4.0%*
Severity: MODERATE
Onset: RAPID
Fainting Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
8.0%*
Severity: MILD
Onset: RAPID
Lightheadedness Incidence:
>9.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
9.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
10.0-30.0%*
Severity: MILD
Onset: EARLY
Flushing Incidence:
11.0-15.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
14.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
19.0-30.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
27.0-63.0%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
38.0%*
Severity: SEVERE
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Remodulin 10mg/ml Solution for Injection

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Remodulin 10mg/ml Solution for Injection(Treprostinil Sodium)
Alcohol and Antihypertensives(Treprostinil Sodium)
Although an interaction is possible, Ethanol (alchohol) and Antihypertensive Agents (drugs used to reduce high blood pressure) may be used together. Ethanol or alchohol-containing beverages may increase the effects of Antihypertensive Agents on your blood pressure. If the blood pressure drops too low while taking Ethanol and Antihypertensive Agents, you may become dizzy or feel faint. To limit this interaction, avoid alcohol-containing beverages while taking medicines to lower your blood pressure. Do not stand or sit up too quickly. Contact your prescriber if you have dizziness which does not go away.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Remodulin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5